Cloud Computing Services is the fastest growing segment fueling the growth of Clostridium Vaccine Market
![]() |
Clostridium Vaccine Market |
The global Clostridium Vaccine
Market is estimated to be valued at US$ 2.3 Bn in 2023 and is expected to
exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in
a new report published by Coherent Market Insights.
Market Overview:
Clostridium Vaccines help prevent
diseases caused by Clostridium bacteria such as blackleg and malignant edema in
animals. The vaccines trigger an immune response in animals that helps them
fight the infection if exposed to the disease-causing bacteria.
Market key trends:
One of the major trends in the
Clostridium vaccine market is the rise in demand for combination vaccines.
Combination vaccines offer convenience of administering multiple vaccines in
one shot which reduces the stress on animals and saves time for farmers and
veterinarians. Researchers are focused on developing new combination vaccines
with expanded coverage against various Clostridium diseases. For instance,
Zoetis Inc offers a combination vaccine called Ultrabac® 7/Somubac® which
protects cattle from 7 clostridial diseases and salmonella.
Segment Analysis
The global Clostridium Vaccine
market is segmented based on product type, animal type, and end user. Based on
product type, the market is divided into Bovine Clostridium Vaccine, Ovine
Clostridium Vaccine, Caprine Clostridium Vaccine, Swine Clostridium Vaccine,
and Others. The bovine Clostridium vaccine segment currently dominates the market
due to the large cattle livestock population globally and high demand for
vaccination to prevent diseases like blackleg.
Key Takeaways
The Global
Clostridium Vaccine Market Size is expected to witness high growth,
exhibiting CAGR of 4.2% over the forecast period, due to increasing prevalence
of clostridial diseases in livestock and growing animal husbandry practices.
Regional Analysis
Asia Pacific is expected to be
the fastest growing region in the Clostridium Vaccine market owing to rising
consumption of meat and increasing focus of market players on emerging
economies in the region. North America currently dominates the market due to large
cattle livestock industry and strict regulations regarding animal health and
welfare.
Key Players
Key players operating in the
Clostridium Vaccine market are Merck Animal Health, Zoetis Inc., Boehringer
Ingelheim GmbH, Elanco Animal Health, Ceva Santé Animale, Virbac SA, Bayer AG,
Intervet Inc., Bimeda, Ouroboros Biologicals, Novartis Animal Health, Hygieia
Biological Laboratories, Valneva SE, and Vetoquinol. These players are focusing
on new product launches and geographical expansion to increase their market
share.
For More Insights
https://www.newsstatix.com/clostridium-vaccine-market-size-share-growth-outlook-2023/
Comments
Post a Comment